Hereditary spastic paraplegia SPG4: what is known and not known about the disease

被引:117
|
作者
Solowska, Joanna M. [1 ]
Baas, Peter W. [1 ]
机构
[1] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
hereditary spastic paraplegia; SPAST; spastin; microtubule endoplasmic reticulum; endosome; AXONAL-TRANSPORT DEFECTS; MOTOR-NEURON DISEASE; MESSENGER-RNA DECAY; AAA ATPASE SPASTIN; PROTEIN SPASTIN; INTRAGENIC MODIFIERS; MICROTUBULE DYNAMICS; MOLECULAR-MECHANISMS; MUTATION SPECTRUM; STRUCTURAL BASIS;
D O I
10.1093/brain/awv178
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in more than 70 distinct loci and more than 50 mutated gene products have been identified in patients with hereditary spastic paraplegias, a diverse group of neurological disorders characterized predominantly, but not exclusively, by progressive lower limb spasticity and weakness resulting from distal degeneration of corticospinal tract axons. Mutations in the SPAST (previously known as SPG4) gene that encodes the microtubule-severing protein called spastin, are the most common cause of the disease. The aetiology of the disease is poorly understood, but partial loss of microtubule-severing activity resulting from inactivating mutations in one SPAST allele is the most postulated explanation. Microtubule severing is important for regulating various aspects of the microtubule array, including microtubule number, length, and mobility. In addition, higher numbers of dynamic plus-ends of microtubules, resulting from microtubule-severing events, may play a role in endosomal tubulation and fission. Even so, there is growing evidence that decreased severing of microtubules does not fully explain HSP-SPG4. The presence of two translation initiation codons in SPAST allows synthesis of two spastin isoforms: a full-length isoform called M1 and a slightly shorter isoform called M87. M87 is more abundant in both neuronal and non-neuronal tissues. Studies on rodents suggest that M1 is only readily detected in adult spinal cord, which is where nerve degeneration mainly occurs in humans with HSP-SPG4. M1, due to its hydrophobic N-terminal domain not shared by M87, may insert into endoplasmic reticulum membrane, and together with reticulons, atlastin and REEP1, may play a role in the morphogenesis of this organelle. Some mutated spastins may act in dominant-negative fashion to lower microtubule-severing activity, but others have detrimental effects on neurons without further lowering microtubule severing. The observed adverse effects on microtubule dynamics, axonal transport, endoplasmic reticulum, and endosomal trafficking are likely caused not only by diminished severing of microtubules, but also by neurotoxicity of mutant spastin proteins, chiefly M1. Some large deletions in SPAST might also affect the function of adjacent genes, further complicating the aetiology of the disease.
引用
收藏
页码:2471 / 2484
页数:14
相关论文
共 50 条
  • [1] Hereditary spastic paraplegia caused by mutations in the SPG4 gene
    Joachim Bürger
    Nuria Fonknechten
    Maria Hoeltzenbein
    Luitgart Neumann
    Elfriede Bratanoff
    Jamilé Hazan
    André Reis
    European Journal of Human Genetics, 2000, 8 : 771 - 776
  • [2] Hereditary spastic paraplegia caused by mutations in the SPG4 gene
    Bürger, J
    Fonknechten, N
    Hoeltzenbein, M
    Neumann, L
    Bratanoff, E
    Hazan, J
    Reis, A
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (10) : 771 - 776
  • [3] Possible anticipation in hereditary spastic paraplegia type 4 (SPG4)
    Reddy, P. Leema
    Seltzer, William K.
    Grewal, Raji P.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (02) : 208 - 210
  • [4] Hereditary spastic paraplegia caused by mutations in the SPG4 gene.
    Burger, JJ
    Fonknechten, N
    Hoeltzenbein, M
    Neumann, L
    Hazan, J
    Reis, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 372 - 372
  • [5] The Prevalence of Hereditary Spastic Paraplegia and the Occurrence of SPG4 Mutations in Estonia
    Braschinsky, Mark
    Lueues, Siiri-Merike
    Gross-Paju, Katrin
    Haldre, Sulev
    NEUROEPIDEMIOLOGY, 2009, 32 (02) : 89 - 93
  • [6] Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia
    Depienne, Christel
    Fedirko, Estelle
    Forlani, Sylvie
    Cazeneuve, Cecile
    Ribai, Pascale
    Feki, Imed
    Tallaksen, Chantal
    Nguyen, Karine
    Stankoff, Bruno
    Ruberg, Merle
    Stevanin, Giovanni
    Durr, Alexandra
    Brice, Alexis
    JOURNAL OF MEDICAL GENETICS, 2007, 44 (04) : 281 - 284
  • [7] Compound heterozygosity in the SPG4 gene causes hereditary spastic paraplegia
    Pantakani, D. V. K.
    Zechner, U.
    Arygriou, L.
    Pauli, S.
    Sauter, S. M.
    Mannan, A. U.
    CLINICAL GENETICS, 2008, 73 (03) : 268 - 272
  • [8] SPG4 founder effect in French Canadians with hereditary spastic paraplegia
    Meijer, Inge. A.
    Dupre, Nicolas
    Brais, Bernard
    Cossette, Patrick
    St-Onge, Judith
    Rioux, Marie-France
    Benard, Melanie
    Rouleau, Guy A.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (02) : 211 - 214
  • [9] MR spectroscopy in patients with hereditary spastic paraplegia type SPG4
    Erichsen, A. K.
    Server, A.
    Nakstad, P. H.
    Tallaksen, C. M. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 296 - 296
  • [10] Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia
    Magariello, Angela
    Muglia, Maria
    Patitucci, Alessandra
    Mazzei, Rosalucia
    Conforti, Francesca Luisa
    Gabriele, Anna Lia
    Sprovieri, Teresa
    Ungaro, Carmine
    Gambardella, Antonio
    Mancuso, Michelangelo
    Siciliano, Gabriele
    Branca, Damiano
    Aguglia, Umberto
    de Angelis, Maria Vittoria
    Longo, Katia
    Quattrone, Aldo
    NEUROMUSCULAR DISORDERS, 2006, 16 (06) : 387 - 390